Review Article

Nasal Expiratory Positive Airway Pressure Devices (Provent) for OSA: A Systematic Review and Meta-Analysis

Table 4

Pre- and postnasal EPAP means, standard deviations, mean differences, and confidence intervals for polysomnography outcomes.

Research studiesOxygen desaturation index (mean/SD, except)Lowest oxygen saturation (mean/SD except)
Author, yearPre-NEPAPPost-NEPAPMD (95% CI) valuePre-NEPAPPost-NEPAPMD (95% CI) value

Colrain et al., 2008 [12]14.6 ± 16.99.9 ± 15.2−4.70 (−13.007, 3.607)0.262182.6 ± 8.685.3 ± 8.42.70 (1.693, 7.093)0.2236
Rosenthal et al., 2009 [16]11.0 ± 17.59.2 ± 14.3−1.80 (−10.363, 6.763)0.675185.0 ± 7.485.1 ± 8.10.10 (−3.96, 4.16)0.9617
Hwang et al., 2009 [20]
Westbrook et al., 2009 [21]
Berry et al., 2011 [18]12.68.6
Kryger et al., 2011 [19]12.67.6
Patel et al., 2011 [13]
Walsh et al., 2011 [17]38.8 ± 27.217.0 ± 11.3−21.80 (−30.732, −12.868)0.0001
Adams 2011 [22]
Hwang et al., 2011 [23]21.8 ± 13.012.1 ± 10.3−9.70 (−15.213, −4.187)0.0008
Massie and Hart 2011 [24]18.84.4
Adams 2012 [25]
Massie 2012 [26]13.78.2
Rossi et al., 2013 [14]33.1 ± 12.235.8 ± 17.42.70 (−6.672, 12.072)0.5637
Deoras et al., 2013 [27]
Mansfield et al., 2013 [28]
Martin et al., 2014 [29]13.8 ± 11.45.0 ± 5.8−8.80 (−12.4, −5.3)<0.0000184.0 ± 5.086.7 ± 16.22.70 (−2.0, 7.45)0.2629
Friedman et al., 2015 [15]16.3 ± 10.88.2 ± 9.0−8.10 (−12.644, −3.556)0.000781.3 ± 6.786.9 ± 5.65.60 (2.777, 8.423)0.0002
Combined means21.2 ± 19.312.4 ± 14.1−8.80 (−11.78, −5.82)<0.0000183.2 ± 6.886.2 ± 11.13.00 (0.89, 5.11)0.005

16 patients.
Combined means of studies included in meta-analysis.
Median (25–75).
NEPAP: nasal EPAP (Provent); SD: standard deviation.